Pro: Should aspirin be continued after cardiac surgery in the setting of thrombocytopenia?
作者信息
Faraday Nauder
机构信息
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.
出版信息
J Cardiothorac Vasc Anesth. 2006 Feb;20(1):112-3. doi: 10.1053/j.jvca.2005.10.006.
Abstract
摘要
相似文献
1
Pro: Should aspirin be continued after cardiac surgery in the setting of thrombocytopenia?问题：在血小板减少的情况下，心脏手术后是否应继续使用阿司匹林？
J Cardiothorac Vasc Anesth. 2006 Feb;20(1):112-3. doi: 10.1053/j.jvca.2005.10.006.
2
Con: Should aspirin be continued after cardiac surgery in the setting of thrombocytopenia?反对观点：在血小板减少的情况下，心脏手术后是否应继续使用阿司匹林？
J Cardiothorac Vasc Anesth. 2006 Feb;20(1):114-6. doi: 10.1053/j.jvca.2005.10.007.
3
Thrombocytopenia corrected by warfarin in antiphospholipid syndrome.
J Rheumatol. 1996 Apr;23(4):769-71.
4
Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice.当代临床实践中急性冠状动脉综合征期间发生血小板减少症的发生率及预后意义。
Circulation. 2009 May 12;119(18):2454-62. doi: 10.1161/CIRCULATIONAHA.108.827162. Epub 2009 Apr 27.
5
Cardiac surgery in a patient with severe thrombocytopenia: how low is too low?
Ann Card Anaesth. 2013 Jul-Sep;16(3):215-7. doi: 10.4103/0971-9784.114258.
6
[No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low dose of acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery].[在冠状动脉搭桥手术后预防静脉移植狭窄方面，与低剂量阿司匹林（每日50毫克）相比，添加双嘧达莫或口服抗凝剂并无优势]
Ned Tijdschr Geneeskd. 1994 Jan 1;138(1):46-7.
7
[No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].与低剂量阿司匹林（每日50毫克）相比，在冠状动脉搭桥手术后预防静脉移植物闭塞方面，添加双嘧达莫或口服抗凝剂并无优势。
Ned Tijdschr Geneeskd. 1993 Oct 23;137(43):2222-3.
8
Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.术前接受依诺肝素治疗的冠状动脉手术患者的肝素抵抗和血小板活化增加。
Eur J Cardiothorac Surg. 2006 Jun;29(6):933-40. doi: 10.1016/j.ejcts.2006.02.007. Epub 2006 May 3.
9
10
[No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery].在冠状动脉搭桥手术后预防静脉移植血管狭窄方面，与低剂量阿司匹林（每日50毫克）相比，添加双嘧达莫或口服抗凝剂并无优势。
Ned Tijdschr Geneeskd. 1994 Feb 19;138(8):426-7.
引用本文的文献
1
Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease.阿司匹林靶向治疗慢性肾脏病中的动脉事件（ATTACK）：一项多中心、前瞻性、随机、开放标签、盲终点、平行组试验的研究方案，旨在比较低剂量阿司匹林与标准治疗用于慢性肾脏病患者心血管疾病一级预防的疗效。
Trials. 2022 Apr 21;23(1):331. doi: 10.1186/s13063-022-06132-z.
2
Risks and benefits of giving early Aspirin within 6 hours of CABG: A retrospective analysis.冠状动脉旁路移植术（CABG）6小时内早期给予阿司匹林的风险与益处：一项回顾性分析。
Pak J Med Sci. 2017 Jan-Feb;33(1):106-110. doi: 10.12669/pjms.331.11563.
3
Does Early Post-operative Administration of Aspirin Influence the Risk of Bleeding After Coronary Artery Bypass Graft Surgery? A Prospective Observational Study.冠状动脉搭桥术后早期给予阿司匹林会影响出血风险吗？一项前瞻性观察研究。
Med Arch. 2015 Dec;69(6):381-3. doi: 10.5455/medarh.2015.69.381-383.
本文引用的文献
1
Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.冠状动脉搭桥术后血小板阿司匹林抵抗的功能和生化评估
Circulation. 2003 Aug 5;108(5):542-7. doi: 10.1161/01.CIR.0000081770.51929.5A. Epub 2003 Jul 21.
2
Aspirin and mortality from coronary bypass surgery.阿司匹林与冠状动脉搭桥手术死亡率
N Engl J Med. 2002 Oct 24;347(17):1309-17. doi: 10.1056/NEJMoa020798.
3
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.抗血小板治疗预防高危患者死亡、心肌梗死和中风的随机试验协作荟萃分析。
BMJ. 2002 Jan 12;324(7329):71-86. doi: 10.1136/bmj.324.7329.71.
4
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.氯吡格雷联合阿司匹林对非ST段抬高急性冠脉综合征患者的影响。
N Engl J Med. 2001 Aug 16;345(7):494-502. doi: 10.1056/NEJMoa010746.
5
Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.血小板糖蛋白IIb/IIIa抑制剂在急性冠状动脉综合征中的当前作用。
JAMA. 2000 Sep 27;284(12):1549-58. doi: 10.1001/jama.284.12.1549.
6
7
8
Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.双嘧达莫和阿司匹林对冠状动脉搭桥术后静脉移植物远期通畅率的影响。
N Engl J Med. 1984 Jan 26;310(4):209-14. doi: 10.1056/NEJM198401263100401.
9
The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.抗血小板治疗对隐静脉冠状动脉旁路移植血管通畅率的影响。
Circulation. 1983 Sep;68(3 Pt 2):II218-21.
10
Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.冠状动脉搭桥术后1年隐静脉移植物通畅情况及抗血小板治疗的效果。退伍军人管理局合作研究的结果
Circulation. 1989 Nov;80(5):1190-7. doi: 10.1161/01.cir.80.5.1190.
Zotero 插件